Both prostaglandin monotherapies significantly reduced mean 24-h IOP as compared with baseline ( P < 0.001 , P < 0.001 , respectively ) , and travoprost demonstrated a lower mean 24-h IOP than tafluprost ( P = 0.044 ) .